Giving Patients Treatment Choice Improves PTSD Outcomes

Share this content:
Giving Patients Treatment Choice Improves PTSD Outcomes
Giving Patients Treatment Choice Improves PTSD Outcomes

FRIDAY, Oct. 26, 2018 (HealthDay News) -- Giving patients with post-traumatic stress disorder (PTSD) their preferred treatment improves adherence and symptoms, according to a study published online Oct. 19 in The American Journal of Psychiatry.

Lori A. Zoellner, Ph.D., from the University of Washington in Seattle, and colleagues randomly assigned 200 patients with PTSD to choice of treatment or no choice. Those assigned to no choice were then randomly assigned to prolonged exposure or sertraline. Acute treatment lasted 10 weeks, and follow-up took place over 24 months.

The researchers found that patients preferred prolonged exposure over sertraline (number needed to benefit [NNTB], 4.5). In intent-to-treat analyses, both prolonged exposure and sertraline showed substantial benefits that were maintained during the follow-up period. There was no differential effect on interviewer-rated PTSD severity, but there was a significant benefit of prolonged exposure over sertraline on interview-rated loss of PTSD diagnosis (NNTB, 7); responder status (NNTB, 5.7); and self-reported PTSD, depression, and anxiety symptoms and functioning (effect sizes, 0.35 to 0.44). Participants receiving their preferred treatment were more likely to be adherent; lose their PTSD diagnosis (NNTB, 3.4); achieve responder status (NNTB, 3.4); and have lower self-reported PTSD, depression, and anxiety symptoms (effect sizes, 0.4 to 0.72).

"To better personalize PTSD care, we must understand the impact of preferences on empirically supported interventions," the authors write.

Pfizer supplied the study medication, and one author disclosed ties to Valent Medical Solutions.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »